Definitions
Sorry, no definitions found. You may find more data at cd-np.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word CD-NP.
Examples
-
The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.
-
"With his extensive knowledge, broad industry network, and history of strong leadership in development-stage biotech companies, we are confident that Mr. Brewer will play an integral role in defining and implementing our clinical development and partnership strategy for CD-NP."
-
"With promising results to date and having just completed enrollment in the first Phase II study of CD-NP in the target patient population, this is an exciting time to join the company, and I look forward to contributing to the advancement of the product and the company at this pivotal stage."
-
-- Nile Therapeutics, Inc. (Nasdaq: NLTX), a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF.
-
MDA, FFSHR award $200,000 grant for developing FSH dystrophy therapy Semel Institute for Neuroscience and Human Behavior awarded $14. 9M to establish IPCN facility Nile Therapeutics to fund ongoing Phase II clinical trial of CD-NP with proposed public offering
THE MEDICAL NEWS Editors 2010
-
Our next steps in the development of CD-NP as therapy for acute heart failure are to finalize the design of a double-blind, placebo controlled Phase IIb study and to discuss that trial design with the FDA and other regulatory authorities.
-
Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed natriuretic peptide.
-
In addition to an initial indication for acute heart failure, CD-NP has potential utility in other indications which include preservation of cardiac function subsequent to acute myocardial infarction (AMI), and prevention of renal damage subsequent to cardiac surgery.
-
Food and Drug Administration (FDA) to support the initiation of the Company's Phase IIb clinical trial with CD-NP for the treatment of acute heart failure, the FDA has placed CD-NP on clinical hold.
-
CD-NP was designed to have direct hemodynamic and renal activity to reduce symptoms of dyspnea, be diuretic and natriuretic and preserve or enhance renal function in heart failure patients.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.